Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Koolen-De Vries syndrome (detection of 17q21.31 region deletion by MLPA) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Otogenetics Usher Multi-Gene NGS Panel Otogenetics United States | 10 | 10 |
|
Otogenetics Hearing Loss and Deafness Multi-Gene NGS Panel Otogenetics United States | 122 | 128 |
|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
WHRN - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 417 | 413 |
|
Centogene AG - the Rare Disease Company Germany | 203 | 194 |
|
Invitae Comprehensive Deafness Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 405 | 219 |
|
Labcorp Genetics (formerly Invitae) LabCorp United States | 32 | 17 |
|
Molecular Otolaryngology and Renal Research Laboratories University of Iowa Hospital and Clinics United States | 16 | 9 |
|
Invitae Inherited Retinal Disorders Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 486 | 293 |
|
Hereditary Hearing Loss and Deafness Panel PreventionGenetics, part of Exact Sciences United States | 362 | 227 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 327 | 300 |
|
PreventionGenetics, part of Exact Sciences United States | 11 | 12 |
|
DFNB31 Sequence Analysis (Prenatal Diagnosis) Baylor Genetics United States | 2 | 1 |
|
Baylor Genetics United States | 2 | 1 |
|
DFNB31 Deletion/Duplication Analysis Baylor Genetics United States | 2 | 1 |
|
DFNB31 Comprehensive - Sequence & Deletion/Duplication Analysis Baylor Genetics United States | 2 | 1 |
|
Usher Syndrome Type 2 and Deafness, Autosomal Recessive 31 (DFNB31) via the WHRN Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.